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http://dx.doi.org/10.1016/j.jfma.201Background/Purpose: To present the results and evaluate the efficacy of endoscopic transna-
sal orbital decompression for dysthyroid orbitopathy.
Methods: Retrospective chart review of patients who underwent endoscopic transnasal orbital
decompression from 1996 to 2010 in one institution. We included 42 orbits of 25 patients. Preoper-
ativeandpostoperativeexaminations includedvisual acuity,Hertelexophthalmometry, tonometry,
exposure keratitis, and diplopia. The measurements of outcome depend on proptosis reduction,
intraocular pressure reduction, and visual acuity improvement of 42 orbits of 25 patients.
Results: There were no surgical complications for the 42 orbital decompressions except one
patient experienced cerebrospinal fluid leak during the operation. Mean proptosis reduction in
all orbits was 1.93  0.25 (mean  standard deviation, p < 0.01) after 1 month postoperatively
and 2.07  0.29 (p < 0.01) after 3 months postoperatively. An average reduction of intraocular
pressure was 4.40  0.72 (p < 0.01) and 4.38  0.80 (p < 0.01) respectively after 1 and 3 months
postoperatively. Visual acuity increased from a preoperative average of 0.45 0.34 to 0.66 0.36
and 0.70 0.35 after 1 and 3months postoperatively. In addition, postoperative relief of exposure
keratitis is also noted.
Conclusion: The transnasal orbital decompression procedure has statistically significant improve-
ments in proptosis, intraocular pressure, and visual acuity. The procedure has obvious benefithave no conflicts of interest relevant to this article.
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Transnasal endoscopic orbital decompression 649in relieving exposure keratitis. Furthermore, there are favorable cosmetic results and rare
complications.
Copyright ª 2012, Elsevier Taiwan LLC & Formosan Medical Association. All rights reserved.Introduction
Dysthyroid orbitopathy is an autoimmune disorder that
results in proptosis and compressive optic neuropathy. This
is caused by an increase in volume of orbital contents,
including the extraocular muscles and orbital fat. However,
dysthyroid orbitopathy is often a self-limited disorder.
Spontaneous resolution occurs in most cases. Only
a minority of patients with severe disease (3e5%) require
aggressive treatments.1,2
Treatment of dysthyroid orbitopathy consists of high-
dose corticosteroids, retrobulbar radiotherapy, immuno-
suppressive agents, and orbital decompression. Systemic
steroids need to be used for months at high doses that have
undesirable side effects. In addition, the signs and symp-
toms may return when the medication is tapered.3
Furthermore, different dose regimens of oral glucocorti-
coid use have not systematically been investigated.4
External beam radiotherapy is effective for optic neurop-
athy in the acute phase of the disease, but it does not
usually provide significant improvement of proptosis.
Furthermore, the few available randomized controlled
trials on the effects of radioiodine therapy on Graves oph-
thalmopathy show that a definite proportion of patients
(approximately 15%) develop new eye disease or experi-
ence progression of preexisting Graves ophthalmopathy
within 6 months after radioiodine administration.4 Decom-
pressive methods have evolved in concert with technical
advances in surgical methods. Since 1911, when Dollinger5
first described surgical orbital decompression, many
different techniques and approaches were proposed. These
methods involve removing one to four of the bony orbital
walls to enable the orbital contents to expand into adja-
cent spaces. This is associated with improvement in prop-
tosis, corneal exposure, and orbital neuropathy. In 1990,
Kennedy et al.6 first described the endoscopic transnasal
medial and inferior wall decompression of thyrotoxic
orbitopathy. The ability to perform this surgery via
a transnasal route under precise endoscopic guidance
without an external scar makes it a more attractive option,
especially because of cosmetic reasons. We have adopted
endoscopic surgery as our treatment of choice for the past
15 years. This retrospective study reviews and presents the
results of 42 orbits of 25 patients who underwent endo-
scopic transnasal orbital decompression.
Materials and methods
Patients
Between July 1996 and May 2010, endoscopic transnasal
orbital decompression was performed on 42 orbits of 25
patients with thyrotoxic orbitopathy at the ENT Depart-
ment of the Kaohsiung Veterans General Hospital. General
anesthesia was used in all cases. There were 14 male and11 female patients with a mean age of 51.2 years (range,
28 to 81 years, Table 1). All patients had been previously
examined at the ophthalmology department and all had
received nonsurgical treatment with corticosteroids
(10e60 mg prednisolone per day orally or under methyl-
prednisolone pulse therapy, MTP, 250 mg every 6 hours)
but in vain (Table 2). Postoperative examination was done
at 1- and 3-month intervals. Preoperative and post-
operative examinations included visual acuity, Hertel
exophthalmometry, tonometry, exposure keratitis, and
diplopia. Otolaryngologic assessment included nasal
endoscopy to identify any sinus or septal pathology. The
presence of sinusitis is a contraindication to endoscopic
decompression. Computed tomography (CT) scans or
magnetic resonance imaging (MRI) of the orbits and the
paranasal sinuses were obtained preoperatively in all
patients. This study was approved by the institutional
review board of Kaohsiung Veterans General Hospital.
Seventeen patients had bilateral surgery and eight
unilateral surgery. There were nine patients who received
one-stage bilateral orbital decompressions and eight in
whom surgery was performed in two stages (Table 2). The
main reason for surgical decompression was severe/acute
proptosis in 13 patients, rapidly decreasing vision caused by
compressive optic neuropathy in seven patients, both
proptosis and decreased vision in four patients, and severe
exposure keratitis in one patient. All patients who received
two-stage operations had symptoms in each eye that
occurred at different times. No patient was operated on for
cosmetic reasons (Table 2). In two cases, nasal septoplasty
was performed concurrently.Surgical technique
All patients were operated on according to the technique
described by Kennedy et al.6 The aim is to remove the
entire medial wall and part of the floor of the orbit so that
the orbital contents can prolapse into the ethmoidal and
maxillary cavities.
After induction of general anesthesia, the patient was in
the supine position on the operating table with the head
slightly elevated to reduce venous pressure at the surgical
site. The sinonasal mucosa was decongested and vaso-
constricted with topical 4% cocaine by nasal packing.
Submucosal injections of 1% lidocaine with epinephrine
1:50,000 were placed along the lateral nasal wall and
middle turbinates.7,8
An uncinectomy preceded the formation of a generous
middle meatal antrostomy to expose the medial and inferior
orbital wall. The endoscopic transnasal approach was used
with complete anterior and posterior ethmoidectomy. The
ethmoid air cells were removed from the agger nasi cells to
the face of the sphenoid. The medial wall over the anterior
and posterior ethmoid sinuses was removed to the skull base
superiorly and posteriorly to the optic nerve canal.
Table 1 Preoperative and postoperative information on orbital decompression patients.
Patient
No./Orbit
Agea,
y/sex
Hertel, mm IOP, mm Hg Visual acuity Diplopia EK
Pre-op Post-op,
1 m
Post-op,
3 m
Pre-op Post-op,
1 m
Post-op,
3 m
Pre-op Post-op,
1 m
Post-op,
3 m
Pre-op Post-op,
1 m
Post-op,
3 m
Pre-op Post-op,
1 m
Post-op,
3 m
1 OD 48F 23 18 23 20 20 20 0.10 0.50 0.50 1 1 1 1 0 0
1 OS 22 17 21 19 18 19 0.30 0.90 0.70 1 1 1 1 0 0
2 OD 37M 18 17 17 18 16 16 0.10 0.70 0.80 0 1 1 0 0 0
2 OS 18 17 18 18 15 16 0.10 0.80 0.70 0 1 1 0 0 0
3 OD 55M 23 21 19 15 16 16 1.00 1.20 1.20 1 1 1 1 0 0
3 OS 23 21 18 19 16 17 1.00 1.20 1.20 1 1 1 1 0 0
4 OD 68M 26 23 20 22 20 19 0.70 1.20 1.20 1 1 1 0 0 0
4 OS 24 23 22 21 16 16 0.10 0.77 0.80 1 1 1 0 0 0
5 OD 30F 20.5 20 20 19 17 17 0.40 1.20 1.20 1 1 1 1 0 0
5 OS 20.5 20 20 20 16 16 0.40 1.20 1.20 1 1 1 1 0 0
6 OD 68M 20 18 18 29 19 19 0.00 0.10 0.10 1 1 1 1 0 0
6 OS 19 18 18 34 14 14 0.05 0.10 0.10 1 1 1 1 0 0
7 OS 52F 18.5 12.5 12.5 20 15 15 0.60 0.75 0.75 1 1 1 1 0 0
8 OD 36F 29 24 23 30 25 21 0.10 0.60 0.60 1 1 1 1 1 1
8 OS 29 23 22 28 25 23 0.30 0.80 1.00 1 1 1 1 1 1
9 OD 74F 12 11 8 12 10 8 0.00 0.00 0.00 1 1 1 1 0 0
10 OD 81M 14 13 13 33 20 20 0.80 0.80 0.80 1 1 1 1 0 0
10 OS 14 13 13 26 19 19 0.40 0.50 0.50 1 1 1 1 0 0
11 OD 31F 19 18 18 19 18 21 0.20 0.40 0.40 1 1 1 1 1 1
11 OS 24 24 22 28 26 26 0.07 0.20 0.40 1 1 1 1 0 0
12 OD 28F 22 20.5 20 19 18 18 0.60 0.80 0.70 1 1 1 0 0 0
13 OD 51M 17 16 16 21 18 18 0.60 0.60 0.80 1 1 1 1 0 0
13 OS 17 15 17.5 22 19 22 0.60 0.60 0.80 1 1 1 1 0 0
14 OD 33F 25 22 21.5 27 23 24 0.90 0.90 0.80 1 1 1 0 0 0
14 OS 23.5 21.5 21 20 20 21 0.80 1.00 0.80 1 1 1 0 0 0
15 OS 28F 17.5 17 17 19 15 15 1.00 0.80 0.80 0 0 0 1 0 0
16 OD 54M 18.5 15.5 15.5 20 18 18 0.69 0.60 0.60 0 0 0 1 0 0
17 OS 53M 19 18 18 30 22 17 0.80 1.00 1.00 1 1 1 1 0 0
18 OD 43M 19 16 16 24 18 18 0.01 0.30 0.30 1 1 1 1 0 0
18 OS 22 19 19 19 18 18 0.30 0.70 0.70 1 1 1 1 0 0
19 OD 74M 18 17 17 21 14 15 0.10 0.10 0.20 1 1 1 1 0 0
19 OS 17 16 17 11 10 10 0.10 0.10 0.10 1 1 1 1 0 0
20 OD 52M 21 20 20 17 15 16 0.80 0.30 0.70 1 1 1 0 0 0
21 OD 49M 22 19 17 29 20 18 0.20 0.60 0.90 1 1 1 0 0 0
21 OS 19 18 18 26 14 21 0.90 1.00 1.00 1 1 1 0 0 0
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Table 2 Characteristics of 25 patients (42 orbits).
Total (n Z 25)
Sex
Male 14 (56%)
Female 11 (44%)
Unilateral 8 (32%)
Bilateral 17 (68%)
One-stage decompression 9
Two-stage decompression 8
Age at surgerya
Mean (range) 51.2 (28e81)
Median 52
Preoperative treatment
Corticosteroids systemically 25 (100%)
Surgical indication
Severe/acute proptosis 13 (52%)
Rapidly decreasing vision 7 (28%)
Both proptosis and decreased vision 4 (16%)
Severe exposure keratitis 1 (4%)
Cosmetic reason 0 (0%)
Postoperative medial muscle resectionb 3 (12%)
a The age at the first surgery of two-stage bilateral orbital
decompressions.
b Postoperative 6 mo to 3 y.
Figure 1 Orbital fat protruding into the left nasal cavity
(middle meatus) after cutting through the periorbita with
a sickle knife. The black curved line is the original anatomy of
the lamina papyracea and the suction tube tip direction is the
antrum of the maxillary sinus.
Transnasal endoscopic orbital decompression 651Meanwhile, the medial orbital wall (lamina papyracea) was
fracturedwith a blunt elevator and removed piecemeal from
the periorbita. The thick medial strut of orbital floor may be
thinned with a cutting bur to facilitate its removal. The
medial orbital floor was then fractured inferiorly and
removed. Bony decompression of the orbital floor must not
extend beyond the infraorbital nerve canal to avoid
damaging the nerve. Excessive decompression of the orbital
floor may also lead to postoperative diplopia or aggravate
a preexisting diplopia.9,10 The periorbita was incised from
posterior to anterior with a sickle knife to allow for maximal
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652 Y.-Y. She et al.expansion of the orbital content to enhance repositioning of
fat and enlarged muscles11 (Fig. 1). Gentle external
compression of the globe allowed identification of any
undivided strands of the periorbita, which should then be
completely incised. In addition, removing thick bone up to
the junction between the posterior ethmoid and anterior
sphenoid sinus was done for decompression. The bone on the
posterior superior extent of the maxillary sinus toward the
pterygomaxillary fossa was also removed for apex decom-
pression. The optic nerve sheath was preserved because of
a risk of infection. Packing with nasal sponge of the nasal
cavity was done at the end of the operation in all patients.
Patients were usually discharged on the second post-
operative day after removal of all nasal packings.
Preoperative and postoperative examinations, which
included Hertel exophthalmometry, tonometry, visual
acuity, examination of the cornea, and record of diplopia,
were performed at the ophthalmology department. Follow-
up assessments were performed at 1 and 3 months
postoperatively.
Statistical analysis
Means and standard deviations (SDs) were calculated with
the Microsoft Excel program. Values were reported as
mean  SD. Variances and comparisons between the pre-
operation and 1 and 3 months postoperation were made
using a paired Student t-test. Statistical significance was
determined by using a p-value less than or equal to 0.05.
Results
Between July 1996 and May 2010, 31 patients with thyro-
toxic orbitopathy were referred for orbital decompression.
Forty-two orbits of 25 patients were available for follow-up
at 1 and 3 months postoperatively. The average follow-up
time is 35.52 months (range, 3e166 months). Only those
with full preoperative and postoperative assessments were
included in the study. All patients underwent an endoscopic
transnasal approach.
Proptosis decreased in all orbits after the decompres-
sion, with a mean decrease of 1.93  0.25 mm, range 0.5 to
6 mm (p < 0.01) 1 month postoperatively and
2.07  0.30 mm, range 0 to 7 mm (p < 0.01) 3 months
postoperatively (Table 3). The preoperative mean Hertel
exophthalmometry value was 20.10  3.61 mm and the
mean postoperative values were 18.17  3.16 and
18.02  3.06 mm 1 and 3 months later. Intraocular pressure
decreased by means of 4.40  0.72 and 4.38  0.80 mmHg,
from preoperative 22.45  5.96 to 18.05  3.75 mmHg
(p < 0.01) 1 month postoperatively and 18.07  3.74 mmHg
3 months postoperatively (p < 0.01, Table 3). Visual acuity
improved from preoperative 0.45  0.34 to 0.66  0.36
(p < 0.01) and 0.70  0.35 (p < 0.01) at 1 and 3 months
postoperatively (Table 3). Measurements made 3 months
later showed no significantly statistical change compared to
the results of 1 month postoperatively.
Vision improved in all patients except for one patient in
whom vision was reduced in the follow-up examination; the
other patient (Patient 9, Table 1) had an orbital decom-
pression for a blind eye. The patient was blind for 1 week
Transnasal endoscopic orbital decompression 653before the surgical decompression. She was transferred to
our hospital due to vision loss. The CT scan revealed optic
nerve stenosis and swelling of extraocular muscle. Dysthy-
roid orbitopathy was diagnosed and the surgical decom-
pression was done soon thereafter. Although there was
a large orbital retrogression postoperatively, there was no
visual improvement in this eye.
Of the 25 patients (42 orbits) who underwent orbital
decompression, 20 patients (35 orbits, 83.3%) had diplopia
in the primary position before the surgery. All the diplopia
persisted and a new-onset diplopia developed in one
patient (two orbits). In addition, exposure keratitis was also
reduced from 17 patients (28 orbits, 66.7%) to two patients
(three orbits, 7.1%) postoperatively.
Complications were rare. One small cerebrospinal fluid
(CSF) leak was identified at the time of decompression. In
this case, the possible dural tear with a small, pulsated leak
of clear fluid was noted over the skull base during the
operation. We completed the surgery and packed the nasal
cavity with a sponge as usual, because the small CSF leaks
may often self-seal because of the tamponade effect of the
orbital fat and the surrounding tissue.12 Postoperatively, the
patientwas given a daily dose of 2 g ceftizoxime and oxacillin
2 g every 6 hours intravenously. Strict bed rest was ordered.
The nasal packing was removed on the second postoperative
day. However, a clear nasal discharge occurred when the
patient bent his head. The patient had no fever or headache.
Surgical reexploration was done on the seventh post-
operative day. The mucosa of the middle turbinate was
harvested and placed over the ostiumof the skull base to seal
the CSF leak. There is no further CSF leakage post-
operatively. The patient was discharged on the second day.
The long-term follow-up result revealed that there were
four patients used of the steroid after 1 to 14 months post-
operatively. One patient operated on for proptosis experi-
enced a decrease in vision of his right eye after 4 months
postoperatively. The visual acuity of his right eye originally
improved from 0.1 to 0.6 after 1 and 3 months post-
operatively. The oral form of prednisolone was prescribed
due to the deterioration of vision, but the outcome of
proptosis reduction persisted. Another two patients both
received the oral form of prednisolone therapy post-
operatively for the worsened vision. This vision loss may be
caused by the postoperative edema at the surgical site. The
visual acuity of these two patients improved 3 months
postoperatively. The other patient used of oral form steroid
to treat increased intraocular pressure 14 months post-
operatively. Symptoms resolved after steroid use.Discussion
Dysthyroid orbitopathy can be divided into two stages: an
acute inflammatory and congestive phase and a chronic
stable phase with hypertrophy and fibrosis of the extra-
ocular muscles, lacrimal gland, and orbital fat.9,13 The first
stage is partially responsive to immunosuppression and
radiotherapy. Corticosteroids are the most commonly used
immunosuppressive agents and useful in patients with optic
neuropathy. However, corticosteroids have little effect on
exophthalmos.9 Immediate decompression surgery as first-
choice therapy does not appear to result in a betteroutcome compared with intravenous glucocorticoids as
first-choice therapy, nor does it obviate the need for
subsequent glucocorticoid therapy.14 Therefore, all
patients in our study received nonsurgical treatment with
corticosteroids at the ophthalmology department preoper-
atively. The patients of the second phase were unrespon-
sive to steroid therapy due to the permanent change of
hypertrophic and fibrotic orbital contents. Surgical treat-
ment is required to treat this stage. Unlike steroids, which
attempt to temporarily control the local inflammatory
process, surgery permanently enlarges the orbital volume
to reduce the orbital pressure and to improve tissue fluid
dynamics.10
Endoscopic orbital decompression was first reported in
1990, with axial proptosis being reduced by amean of 5.7 mm
when combined with lateral orbitotomy and 4.7 mm when
decompressed by an endoscopic approach alone.3 However,
only two patients (three orbits) underwent a purely endo-
scopic decompression. As other surgeons have developed the
technique, reported mean reductions in proptosis are
different. Wee et al.15 sorted the reported series of a purely
endoscopic approach for orbital decompression from 1990 to
2002. There are a total of 150 orbits of 10 series with mean
reductions ranging from 3.0 mm to 4.7 mm. The largest series
was reported by Neugebauer et al.16 with the mean recession
of 3.0 mm of 42 orbits. The retrogression was varied with the
degree of medial wall and floor removed. The onset or
progression of diplopia may not reflect a complication of
surgery so much as the sequela of a good decompression.
New-onset diplopia is more common in patients undergoing
more extensive decompressions.16 In our series, we reported
a reduction in proptosis by an average of 1.93  0.25 mm,
range 0.5 to 6 mm 1 month postoperatively and
2.07  0.30 mm, range 0 to 7 mm, at 3 months post-
operatively. Even the lower mean reduction of our study
compared with the previous similar studies was noted, and
the significant clinical improvement of intraocular pressure
and visual acuity was demonstrated in our series.
Furthermore, 83.3% of our patients had diplopia preop-
eratively. Postoperatively, the diplopia persisted and one
patient (two orbits) experienced new-onset diplopia.
Meanwhile, the result of our study showed obvious reduc-
tion of exposure keratitis from 28 orbits (66.7%) preopera-
tively to three orbits (7.1%) postoperatively. The low
incidence of postoperative new-onset diplopia and obvious
reduction of exposure keratopathy reveal a proper medial
wall and floor decompression result in significant improve-
ment of visual acuity and intraocular pressure reduction
rather than a greater ocular recession.
Comparing the endoscopic transnasal orbital decom-
pression with other traditional methods, the intranasal
endoscope has significantly improved anatomic visualiza-
tion of the nose and paranasal sinuses. Thus, it permits
a more complete medial orbital decompression. If in the
hands of an experienced sinus endoscopist, transnasal
orbital decompression appears to be a safe procedure that
can be performed with a minimum of morbidity. The scar of
an external ethmoidectomy and the morbidity of a Cald-
well-Luc antrotomy are avoided.6 Almost all studies show
the efficacy and relative safety of orbital decompression;
however, the available studies do not allow any meaningful
comparison of the available techniques.14 In our study, all
654 Y.-Y. She et al.patients were operated on by the same surgeon. There
were no surgical complications for the 42 orbital decom-
pressions except for one small CSF leak that occurred in
1996, the first year of our study. This finding demonstrates
the importance of an experienced endoscopist for the
transnasal orbital decompression surgery.
Although CSF leak is a relatively frequent postoperative
complication in transnasal endoscopic procedures, it is
rarely associated with endoscopic transnasal orbital
decompression mentioned in the literature. Extension of
postoperative CSF leak may range from either minor
subcutaneous CSF collection resolving without any treat-
ment, puncture of subcutaneous collections, asymptomatic
CSF collections in postoperative imaging, pseudomeningo-
cele, or overt leakage from the surgical site or through the
nose or ear.17 If surgical repair is needed, the goal of
management is to create and maintain a watertight seal to
decrease the risk of bacterial infection (particularly if the
leak is into a sinonasal cavity) or aseptic meningitis from
accumulating blood in the subarachnoid space. The loca-
tion and size of the dural tear determine the types of repair
procedure, including a patch graft of autogenous tissue
and/or tissue sealant to suturing of the dura and/or tissue
sealant.18 During repair, the endoscopic approach provided
benefits with a magnified and illuminated view of the
surgical field.12
Baldeschi et al.19 described three of a sample of 239
patients with Graves ophthalmopathy who underwent
rehabilitative orbital decompression during the static
phase. Any types of orbital decompression were included.
Eleven who were treated with perioperative systemic
glucocorticoids to prevent postoperative edema at the
surgical site were excluded. The incidence of reactivation
of Graves ophthalmopathy after rehabilitative bony
decompression surgery was 1.3%. Choe et al.20 collected
the outcome data of 28 eyes of 17 patients between 6 and
12 weeks postoperatively. They reported that three orbits
underwent medial orbital decompression (17%) and two
underwent lateral orbital decompression (20%) and
required additional therapy for persistent or recurrent
compressive optic neuropathy. The medial orbital decom-
pression was performed through a transcaruncular incision
in their study. In our study, no patient required additional
surgical decompression on long-term follow up. Three
patients with a postoperative decrease in vision were
successfully treated with steroids. Furthermore, it is
debatable whether worsening of the disease post-
operatively should be considered the natural progression of
the active phase despite surgical intervention or a direct
consequence of surgery.
A purely endoscopic transnasal orbital decompression
has some limitations. Ordinarily, all patients have one
opportunity to receive the transnasal orbital decompres-
sion. Furthermore, decompression of the medial wall and
floor only may result in significant medial orbital prolapse.
This imbalance may cause diplopia postoperatively.15
A worsening of extraocular muscle balance may follow
orbital decompression, with reported incidences as high as
69% after successful surgery.21 There were three patients
(four orbits) of our study who went on to have squint
surgery and medial muscle resection 6 months to 3 years
later due to strabismus (Table 2). In addition, one patientunderwent trabeculectomy 5 months later due to the
rebounding intraocular pressure. One patient accepted
levator muscle resection surgery after orbital decompres-
sion 6 months later. These changes in ocular motility should
be anticipated as common sequela of decompression and
are not considered surgical complications.7 The timing and
order of surgery for Graves ophthalmopathy is as suggested:
orbital decompression, then squint surgery, then lid
lengthening with or followed by blepharoplasty/brow-
plasty, because side effects of the preceding step can
interfere with the step that follows.14
Some authors have suggested that severe septal devia-
tion is a contraindication to endoscopic orbital surgery. In
our series, we treated two of our patients who required
a septoplasty at the time of surgery.
Conclusion
Transnasal endoscopic orbital decompression surgery has
better anatomic visualization of the nose and paranasal
sinuses and permits a more complete medial orbital
decompression. In our series, it has statistically significant
improvements in proptosis, intraocular pressure, and visual
acuity. The procedure is obviously beneficial in relieving
exposure keratitis. Furthermore, there are favorable
cosmetic results and rare complications. However, an
experienced endoscopist for the transnasal orbital decom-
pression surgery is necessary. Some patients need to accept
additional squint surgery postoperatively due to the
changed ocular motility.
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